A systematic review of treatment outcomes in localised and metastatic spermatocytic tumors of the testis.
Josias Bastian GroggKym SchneiderPeter-Karl BodeMarian Severin WettsteinBenedikt KranzbühlerDaniel EberliTullio SulserJoerg BeyerThomas HermannsChristian Daniel FankhauserPublished in: Journal of cancer research and clinical oncology (2019)
The published literature does neither support the use of testis sparing surgery nor adjuvant therapy. Patients with aggressive variants or larger tumors were more likely to have metastases and develop recurrences within the first few years. Patients with metastatic disease have a limited life expectancy and metastatic spermatocytic tumors are not as responsive to chemotherapy as germ cell cancers.
Keyphrases
- germ cell
- squamous cell carcinoma
- small cell lung cancer
- minimally invasive
- systematic review
- coronary artery bypass
- randomized controlled trial
- locally advanced
- robot assisted
- drug delivery
- coronary artery disease
- cancer therapy
- radiation therapy
- atrial fibrillation
- percutaneous coronary intervention
- meta analyses